{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:05:20Z","timestamp":1760238320966,"version":"build-2065373602"},"reference-count":46,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>The aim of this study was to analyze if registered drug packs of antibiotics are in accordance with national guidelines for prostatitis treatment regard to the amount of drug units.; Methods: Croatian, UK (NICE), Australian, Spanish and Slovenian national guidelines were analyzed in this study. Results: Comparing treatment guidelines with registered drug packs resulted in perfect accordance only for drug packs registered in the UK with the NICE guidelines, where even split-pack dispensing is possible. Interestingly, when comparing drug packs registered in the UK with treatment proposed in the national guidelines of Croatia, Italy, Spain, Australia, USA and Slovenia, they matched almost perfectly. In other investigated countries, registered drug packs\u2019 national guidelines\u2019 analysis showed mismatch in 25\u2013100% of recommendations (Italy and Slovenia, respectively). Conclusions: Mismatch between registered drug packs that are dispensed to patients and treatment guidelines may result in excess units of antimicrobials that may be misused by the patient in the future, or excess antimicrobials may become unnecessary waste, further promoting antimicrobial resistance. Greater accordance of registered drug packs of antimicrobials with treatment guidelines may lower rates of antimicrobials misuse.<\/jats:p>","DOI":"10.3390\/healthcare10071158","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T04:12:01Z","timestamp":1655871121000},"page":"1158","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Registered Drug Packs of Antimicrobials and Treatment Guidelines for Prostatitis: Are They in Accordance?"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7921-8218","authenticated-orcid":false,"given":"Ivan","family":"Jerkovic","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University Hospital of Split, Spinciceva 1, 21 000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7927-5311","authenticated-orcid":false,"given":"Ana","family":"Seselja Perisin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9316-5538","authenticated-orcid":false,"given":"Josipa","family":"Bukic","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5126-3869","authenticated-orcid":false,"given":"Dario","family":"Leskur","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-0635","authenticated-orcid":false,"given":"Josko","family":"Bozic","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9508-9383","authenticated-orcid":false,"given":"Darko","family":"Modun","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7878-7988","authenticated-orcid":false,"given":"Jonatan","family":"Vukovic","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7018-4947","authenticated-orcid":false,"given":"Doris","family":"Rusic","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Split School of Medicine, Soltanska 2, 21 000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"ref_1","unstructured":"Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629\u2013655."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.ARBA-0009-2017","article-title":"Antimicrobial Resistance: A One Health Perspective","volume":"6","author":"McEwen","year":"2018","journal-title":"Microbiol. Spectr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bcp.2016.09.025","article-title":"Antibiotics in late clinical development","volume":"133","author":"Fernandes","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10096-019-03490-6","article-title":"Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome","volume":"38","author":"Klotz","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13643-021-01577-w","article-title":"Factors that influence adherence to surgical antimicrobial prophylaxis (SAP) guidelines: A systematic review","volume":"10","author":"Hassan","year":"2021","journal-title":"Syst. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13756-019-0495-5","article-title":"Evaluation of accordance of antibiotics package size with recommended treatment duration of guidelines for sore throat and urinary tract infections","volume":"8","author":"Rusic","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_7","first-page":"231","article-title":"Antibiotics in the environment: Causes and consequences","volume":"93","author":"Polianciuc","year":"2020","journal-title":"Med. Pharm. Rep."},{"key":"ref_8","unstructured":"Agency for Medicinal Products and Medical Devices (2022, January 28). Medicinal Products Database, Available online: http:\/\/www.halmed.hr\/en\/Lijekovi\/Baza-lijekova\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bcpt.13322","article-title":"Correlation of registered drug packs with Maastricht V\/Florence Consensus Report and national treatment guidelines for management of Helicobacter pylori infection","volume":"126","author":"Jukic","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bcpt.12905","article-title":"Correlation of Recommendations of Treatment Guidelines and Frequently Prescribed Antibiotics: Evaluation of Their Pharmaceutical Pack Size","volume":"122","author":"Mukherjee","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/1753-6405.12385","article-title":"The match between common antibiotics packaging and guidelines for their use in Australia","volume":"39","author":"McGuire","year":"2015","journal-title":"Aust. N. Z. J. Public Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13756-020-00724-7","article-title":"The potential negative impact of antibiotic pack on antibiotic stewardship in primary care in Switzerland: A modelling study","volume":"9","author":"Furi","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_13","first-page":"571","article-title":"Prostatitis: Prevalence, health impact and quality improvement strategies","volume":"69","author":"Bajpayee","year":"2012","journal-title":"Acta Pol. Pharm."},{"key":"ref_14","first-page":"290","article-title":"Common Questions about Chronic Prostatitis","volume":"93","author":"Holt","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"ref_15","first-page":"254","article-title":"ISKRA Guidelines on Diagnostics and Treatment of Prostatitis\u2014Croatian National Guidelines","volume":"139","author":"Kraus","year":"2017","journal-title":"Lije\u010d. Vjesn."},{"key":"ref_16","unstructured":"National Institute for Health and Care Excellence (2022, January 28). Prostatitis (Acute): Antimicrobial Prescribing\u2014NICE Guideline (NG110). Available online: https:\/\/www.nice.org.uk\/guidance\/ng110."},{"key":"ref_17","first-page":"4","article-title":"Prostatitis Diagnosis and treatment","volume":"42","author":"Dickson","year":"2013","journal-title":"Aust. Physician"},{"key":"ref_18","unstructured":"Fern\u00e1ndez Urrusuno, R., Serrano Martino, C., and Grupo de Trabajo de la Gu\u00eda (2018). Gu\u00eda de Terap\u00e9utica Antimicrobiana del \u00c1rea Aljarafe, Distrito Sanitario Aljarafe-Sevilla Norte y Hospital San Juan de Dios del Aljarafe. [3rd ed.]. Available online: https:\/\/portal.guiasalud.es\/wp-content\/uploads\/2018\/12\/GPC_578_Antimicrobianos_Aljarafe_2018.pdf."},{"key":"ref_19","unstructured":"(2015). Raccomandazioni in Tema di Infezioni delle vie Urinarie, Societ\u00e0 Italiana di Urologia. [1st ed.]. Available online: https:\/\/www.siu.it\/linee-guida\/raccomandazioni-siu\/2015-raccomandazioni-siu\/raccomandazioni-in-tema-di-infezioni-delle-vie-urinarie."},{"key":"ref_20","first-page":"114","article-title":"Urogenital Tract Infections","volume":"69","author":"Logar","year":"2018","journal-title":"Farm. Vestn."},{"key":"ref_21","unstructured":"AGREE Next Steps Consortium (2022, June 11). The AGREE II Instrument [Electronic Version]. Available online: https:\/\/www.agreetrust.org\/wp-content\/uploads\/2017\/12\/AGREE-II-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf."},{"key":"ref_22","unstructured":"(2022, January 28). The Electronic Medicines Compendium. Available online: https:\/\/www.medicines.org.uk\/emc#gref."},{"key":"ref_23","unstructured":"The Therapeutic Goods Administration (2022, January 28). ARTG Search, Available online: https:\/\/tga-search.clients.funnelback.com\/s\/search.html?query=&collection=tga-artg."},{"key":"ref_24","unstructured":"MZ JAZMP ZZZS NIJZ (2022, January 28). Centralna Baza Zdravil. Available online: http:\/\/www.cbz.si\/cbz\/bazazdr2.nsf\/Search\/$searchForm?SearchView."},{"key":"ref_25","unstructured":"Agenzia Italiana del Farmaco (2022, January 28). La Banca Dati Farmaci, Available online: https:\/\/farmaci.agenziafarmaco.gov.it\/bancadatifarmaci\/home."},{"key":"ref_26","unstructured":"CIMA (2022, January 28). Find Your Medicine Here. Available online: http:\/\/cima.aemps.es\/cima\/publico\/home.html."},{"key":"ref_27","unstructured":"European Centre for Disease Prevention and Control (2022, April 02). Country Summaries AER-EARS-Net. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Country%20summaries-AER-EARS-Net%20202019.pdf."},{"key":"ref_28","unstructured":"Australian Commission on Safety and Quality in Health Care (2022, April 02). AURA 2019 Third Australian Report on Antimicrobial Use and Resistance in Human Health, Available online: https:\/\/www.safetyandquality.gov.au\/sites\/default\/files\/2019-06\/AURA-2019-Report.pdf."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.pop.2010.04.007","article-title":"Prostatitis: Acute and chronic","volume":"37","author":"Ramakrishnan","year":"2010","journal-title":"Prim. Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/bju.13101","article-title":"Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis\/chronic pelvic pain syndrome: A consensus guideline","volume":"116","author":"Rees","year":"2015","journal-title":"BJU Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/pcan.2016.8","article-title":"Chronic prostatitis\/chronic pelvic pain syndrome: A review of evaluation and therapy","volume":"19","author":"Polackwich","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Marquez-Algaba, E., Burgos, J., and Almirante, B. (2022). Pharmacotherapeutic interventions for the treatment of bacterial prostatitis. Expert Opin. Pharm., accepted.","DOI":"10.1080\/14656566.2022.2077101"},{"key":"ref_33","unstructured":"Bonkat, G., Bartoletti, R., Bruy\u00e8re, F., Cai, T., Geerlings, S.E., K\u00f6ves, B., Schubert, S., Pilatz, A., Veeratterapillay, R., and Wagenlehner, F. (2022, June 11). European Association of Urology. EAU Guidelines on Urological Infections. Available online: https:\/\/uroweb.org\/guidelines\/urological-infections\/chapter\/the-guideline."},{"key":"ref_34","first-page":"e0053421","article-title":"Risk Factors for Relapse in Acute Bacterial Prostatitis: The Impact of Antibiotic Regimens","volume":"31","author":"Pigrau","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ajic.2018.01.008","article-title":"Patient compliance with antimicrobial drugs: A Chinese survey","volume":"46","author":"Tong","year":"2018","journal-title":"Am. J. Infect. Control"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10729-020-09523-3","article-title":"Predicting and improving patient-level antibiotic adherence","volume":"23","author":"Rao","year":"2020","journal-title":"Health Care Manag. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s12664-018-0916-z","article-title":"Comparison between daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled trial","volume":"37","author":"Shahbazi","year":"2018","journal-title":"Indian J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ijantimicag.2019.06.015","article-title":"Comparison of antibiotic treatment guidelines for urinary tract infections in 15 European countries: Results of an online survey","volume":"54","author":"Malmros","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1086\/652861","article-title":"Treatment of Bacterial Prostatitis","volume":"50","author":"Lipsky","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fphar.2020.00504","article-title":"Pharmacological Interventions for Bacterial Prostatitis","volume":"11","author":"Xiong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_41","first-page":"20172687","article-title":"Predicting drug resistance evolution: Insights from antimicrobial peptides and antibiotics","volume":"285","author":"Yu","year":"2018","journal-title":"Proc. Biol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Kornfalt Isberg, H., Hedin, K., Melander, E., Molstad, S., and Beckman, A. (2019). Increased adherence to treatment guidelines in patients with urinary tract infection in primary care: A retrospective study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0214572"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e12775","DOI":"10.1111\/hel.12775","article-title":"Adherence to Maastricht V\/Florence consensus report for the management of Helicobacter pylori infection among primary care physicians and medical students in Croatia: A cross-sectional study","volume":"26","author":"Jukic","year":"2021","journal-title":"Helicobacter"},{"key":"ref_44","unstructured":"Australian Government Department of Health (2022, February 02). New Labelling for Antibiotics in Australia, Available online: https:\/\/www.health.gov.au\/news\/new-labelling-for-antibiotics-in-australia."},{"key":"ref_45","unstructured":"Pharmaceutical Services Negotiating Committee (2022, February 02). Special Containers and Products Requiring Reconstitution. Available online: https:\/\/psnc.org.uk\/dispensing-supply\/dispensing-a-prescription\/special-containers\/)."},{"key":"ref_46","unstructured":"GOV.UK Department of Health & Care (2022, February 02). Closed Consultation Original Pack Dispensing and Supply of Medicines Containing Sodium Valproate, Available online: https:\/\/www.gov.uk\/government\/consultations\/original-pack-dispensing-and-supply-of-medicines-containing-sodium-valproate\/original-pack-dispensing-and-supply-of-medicines-containing-sodium-valproate."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/10\/7\/1158\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:37:11Z","timestamp":1760139431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/10\/7\/1158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["healthcare10071158"],"URL":"https:\/\/doi.org\/10.3390\/healthcare10071158","relation":{},"ISSN":["2227-9032"],"issn-type":[{"type":"electronic","value":"2227-9032"}],"subject":[],"published":{"date-parts":[[2022,6,22]]}}}